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Abstract 
Previous studies have shown that phytoestrogens exhibit an anti-proliferative effect on breast cancer cells. 
This project used HPLC to isolate components of the phytoestrogens. These components were then 
applied to MCF7 and T47D cell lines to determine their effect on cell proliferation.  The results suggest 
that black cohosh has the most anti-proliferative effect.  
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Introduction 
As women age, production of the hormone estrogen secreted by the ovaries decreases.  Estrogen 
is a hormone that regulates the menstrual cycle in women.  The decreasing production and circulation of 
estrogen in the body can cause women, usually in their late 40s or 50s, to feel some uncomfortable 
symptoms.  This inevitable time in a women’s life is referred to as menopause.  During menopause, 
women typically feel the effects of several symptoms including, but not limited to, irregular periods, hot 
flashes, sleeplessness, emotional instability and incontinence (Nordqvist, 2012). Women have taken two 
routes to relieve these symptoms: estrogen replacement therapy and phytoestrogens.  
Estrogen replacement therapy is a method of relieving symptoms of menopause. This is a 
treatment that includes taking estrogen with or without progestin (a synthetic form of progesterone). 
Progesterone is another hormone produced by the ovaries that prepares the female body for pregnancy. 
There are some extrinsic benefits to taking supplemental estrogen. These include the reduction in risk of 
disease associated with lower levels of estrogen, such as osteoporosis, coronary artery disease, and colon 
cancer. The negative effects of taking estrogen supplements include an increase in the risk of breast 
cancer, heart disease, blood clots and stroke (Mayo Clinic, 2012). 
Many women choose to use hormone replacement therapy to alleviate the effects of hormone 
imbalance.  Supplements are produced synthetically and cause other health risks.  According to a study by 
Francine Grodstein and colleagues published in the Archives of Internal Medicine" (Grodstein et al, 
2008) artificial estrogen replacements can increase the risk of stroke.  Studies by De Prithwish and 
colleagues demonstrated a decreased breast cancer risk as women decreased artificial estrogen 
replacement therapy (DePrithwish et al, 2010).  Beral et al showed an increased risk of ovarian cancer 
with use of estrogen supplements (Beral et al, 2007).  Cancer is not the only risk that increases with the 
increased use of artificial estrogen.  Romieu et al showed a direct correlation between artificial estrogen 
use and an increased risk of developing asthma (Romieu et al., 2010). 
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Another method of reducing the symptoms of menopause is by using phytoestrogen supplements.  
Phytoestrogen supplements are over the counter dietary supplements targeted towards post-menopausal 
women.  These supplements are generally plant extracts which may include many different types of 
phytoestrogens in them (Setchel, 2010). Phytoestrogens are a group of chemicals that are structurally 
similar to the hormone estrogen. While estrogen replacement therapy has been linked to breast cancer, 
there have been mixed results linking breast cancer to phytoestrogens. Some preliminary results suggest 
that phytoestrogens act similarly to estrogen and may increase the risk of breast cancer. It is suggested 
that phytoestrogens mimic estrogen by activating the estrogen receptor (Rice, 2006).  
Phytoestrogens are found in foods such as soy, flaxseed, sprouts, and peas. There are three types 
of known phytoestrogens: lignans, isoflavones, and coumestans (Glazier & Bowman, 2001). Their 
relationship can be seen below in Figure One.  
 
Figure 1: Type of Phytoestrogens (Glazier & Bowman, 2001) 
 
The structural similarity between estradiol (the main form of estrogen) and phytoestrogens can be 
seen below in Figure Two. 
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Figure 2: Chemical Structures of Testosterone, Estrogen, and the Major Classes of Phytoestrogens (Rice & Whitehead, 
2006; Rice & Whitehead, 2006) 
 
There are many different phytoestrogen supplements available; they can be taken in the form of 
pills, powders, and teas. Also, anecdotal evidence suggests that consuming large amounts of foods that 
contain these phytoestrogens, such as soy, could have an effect on menopause symptoms and possibly 
breast cancer cell growth. More research needs to be done to reach valid conclusions about which specific 
phytoestrogens affect the risk of breast cancer (Barbour, 2011) and what their mechanism of action might 
be. . 
Commercial Phytoestrogen Supplements 
 In the work presented here, three commercial herbal extracts were tested for their anti-
proliferative effects on breast cancer cell growth: Promensil, Black Cohosh and Natrol Soy. Other studies 
conducted on these and similar products have produced mixed results.  A study conducted on red clover 
isoflavone found in Promensil, showed a reduction in breast density after 12 months (Atkinson, et al., 
2004). While the phytoestrogen components of Black Cohosh remain mostly unknown, formononeticn 
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has been identified in trace amounts in the roots and rhizomes of Black Cohosh (Al-Amier, Eyles, & 
Craker, 2012).  Natrol soy contains a large amount of isoflavones, the most prominent one being daidzein 
7-βglucoside.  Natrol soy has been shown to significantly reduce chemically induced breast cancer in 
animal trials (Setchell, 1998). 
Cell Lines  
The two cell lines used in these studies are the MCF7 and T47D cell lines.  Both cell lines 
originated from breast cancer tissue and are often used as models when studying the effects of compounds 
on estrogen sensitive cells.  The MCF7 cell line was established by Dr. Herbert Soule in 1970 (Levenson 
& Jordan, 1997).  Dr. Soule derived the cell line from a pleural effusion taken from a 69-year-old patient 
with metastatic breast cancer.  The MCF7 cells were of particular interest due to the fact that the hormone 
treatment that the patient was undergoing was significantly more effective in this patient than in breast 
cancer patients (Levenson & Jordan, 1997).  When the cells were grown in vitro they showed no real 
change in growth rate with the addition of estrogen, but when grown in an athymic mouse the 
proliferation rate increased.  The reason for this difference is that the initial cell culture medium that the 
cells were grown in contained phenol red, which has a very similar chemical structure to estrogen 
(Levenson & Jordan, 1997).  Once the phenol red was removed the cells became extremely sensitive to 
estrogen, making them an ideal model to use when studying the effects of estrogen on cell growth.   
T47D cells differ from MCF7 cells in a few ways. Several classes of proteins are expressed 
differently between them.  In T47D cells specific proteins involved in cell growth stimulation, anti-
apoptosis mechanisms, and carcinogenesis have been shown to be  more strongly expressed,  while in 
MCF7 cells proteins involved in transcriptional and apoptotic regulation are more strongly expressed 
(Aka & Lin, 2011). This information is important as it means the cell lines may react differently to the 
phytoestrogen products.  The T47D cell line also has a fluorescent variation called T47D-KBluc which 
was developed by transfecting normal T47D cells with a reporter construct coupled to the endogenous 
response elements for the estrogen receptors ERα and ERβ (Wilson, Bobseine, & Gray Jr, 2004). When a 
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compound binds to the estrogen receptor of this cell line, the luciferase reporter gene is activated.  Use of 
this cell line allows the determination of whether or not a compound binds to the estrogen receptor of the 
cell. 
PCNA and Caspase 
Two proteins were used to measure the anti-proliferative effects of the phytoestrogen 
supplements.  These proteins are PCNA and Caspase. 
PCNA 
 Proliferating Cell Nuclear Antigen (PCNA) is a protein that assists cell growth by recruiting 
necessary replication factors to the DNA replication complex (Moldovan, Pfander, & Jentsch, 2007).  
PCNA plays a number of roles in replication, including binding DNA polymerases to the DNA, binding 
to DNA replication related proteins, and repairing any DNA lesions created in the S phase.  Without 
PCNA, replication could not occur, leading to no growth of the cells (Moldovan, Pfander, & Jentsch, 
2007).  PCNA is often used as a proliferation marker by detecting the levels of protein in the cells to 
indicate the amount of proliferation. 
Caspase  
 Caspases are a class of proteases involved in the apoptosis of cells (Goodsell, 2004).  Once the 
apoptosis signal has been received by the cell, caspases act by cleaving important proteins in the cell into 
small pieces, deactivating them and allowing for easier degradation (Goodsell, 2004).  Caspase is used as 
a cell apoptosis marker by detecting the amount of caspase in the cells to indicate levels of apoptosis. 
Previous Research 
Jessica Caron Thesis  
 
The proliferative effects of an OTC phytoestrogen extract, Promensil, and 17B-estradiol were 
tested using MCF7 cells (Caron, 2007). MCF7 cells were cultured in DMEM with 10% fetal bovine 
serum, 584 mg/L glutamine, and 1% non-essential amino acids. After 12 hours the cells were plated in 
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phenol red free media. The compounds 17-estradiol, genistein or Promensil extract were added to the 
cells 24 hours after exposure to phenol red free media ranging  in concentration from below physiologic 
to pharmacological. A pure genistein standard was used since previous research suggested that genistein 
is a major constituent of Promensil.  Estradiol produced a "u-shaped" curve meaning that the highest 
proliferative effects were found in the lowest and highest concentrations tested, 10 
-12
and 10
-7 
M. 
Genistein produced half a "u-shaped" curve with the highest growth found at 10
-7 
M concentration of 
genistein. Growth was measured as a percentage of the control. Finally, there was an inverse relationship 
between cell growth and Promensil concentration. At 100% Promensil concentration the rate of cell 
proliferation was at its lowest, while at 0% Promensil the rate of cell proliferation was at its highest.  
The estrogenic responsiveness of MCF7 cells was then tested by comparing the results of a 
pharmaceutical concentration of 10
-7
 M for estradiol and genistein and 100% Promensil. The data showed 
no increase in cell proliferation for estradiol and genistein but a significantly lower rate for the Promensil. 
This further supports the hypothesis that Promensil has an inhibitory effect on cell growth and that 
genistein is not its main active constituent.  
Furthermore, a marker of apoptosis was used to determine the cause for the inhibitory effects 
caused by the Promensil extract. A caspase-3 immunoblot was performed and bands for procaspase-3, an 
inactive precursor to caspase-3, were seen in samples treated with genistein and Promensil. This 
suggested that phytoestrogens play some role in the upregulation of the caspase pathway. (Caron, 2007) 
Park and Patchel Paper 
The anti-proliferative properties of methanol extracts of additional commercial phytoestrogen 
products were tested on MCF7 cells (Park and Patchel, 2011). Three separate phytoestrogen extracts were 
tested: Promensil, Black Cohosh and Natrol Soy.  Cell counts were performed every 24 hours for 72 
hours after exposure to phytoestrogen media. After 72 hours the cells were collected immunoblotted for 
the protein PCNA (proliferating cell nuclear antigen). The authors predicted that lower levels of cell 
proliferation would be found in the cells exposed to phytoestrogens. The cell counts showed significant 
anti-proliferative effects after 48 hours with Natrol soy having the least anti-proliferative effect. A second 
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proliferation assay was conducted testing the effects at different concentrations of extract: 2%, 1%, and 
0.5%. Two percent had the lowest cell counts; Promensil showed the biggest anti-proliferative effect and 
Natrol Soy the smallest. Results of immunoblots showed lower levels of PCNA for MCF7 cells treated 
with Promensil and Black Cohosh and higher levels of cell proliferation with Natrol Soy. (Park and 
Patchel, 2011) 
Methods and Materials  
Cell Culture 
MCF7 and T47D cells were cultured in an incubator at 37 C with 5% CO2. The MCF7 cells were 
grown in Dulbecco’s Modified Eagle Medium (DMEM) with (V/V) 10% fetal bovine serum, 0.1% 
insulin, and 1% Penicillin and T47D cells were grown in RPMI with (V/V) 10% fetal bovine serum, 0.2% 
insulin, and 1% Penicillin. For each experiment the cells were grown in 24 well plates at an initial 
concentration of 75000 cells per well. They were initially given 24 hours to adhere to the wells and then 
the media was replaced with phenol red free DMEM with 10% charcoal stripped fetal bovine serum, 0.1% 
insulin, and 1% Penicillin. After a 24 hour period, the cells were subjected to experimental conditions. 
High Performance Liquid Chromatography (HPLC) 
HPLC was performed using the method described in Setchell et al (2001) and Jessica Caron’s 
Thesis (2007).The sample was injected in a volume of 10 µL and a flow rate of 1 mL per minutes onto a 
reverse phase C18 250 X 4.6 mm column. After the injection the column was washed with 10mM 
ammonium acetate and 0.1% triflouroacetic acid (TFA) for two minutes. After this period, it was eluted 
with a gradient of 10 mM ammonium acetate, 0.1% TFA (100-50%) and acetonitrile (0-50%) for 22 
minutes. It was then held isocratic until the end of the run. Absorbance at 256 nm was measured 
throughout the run. Four samples were collected: a peak and finger print region of both Promensil and 
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methanol. The fingerprint region was collected from 1.5 to 7 minutes and the peak region was collected 
from 21.5 to 25 minutes. 
Experimental Conditions 
After the MCF7 and T47D cells were plated and the media was switched, the cells were exposed 
to experimental conditions. For the estrogen sensitivity assay, the cells were treated with two different 
concentrations of estradiol: 10
-9
 and 10
-8
. The control was the same volume of ethanol that was used to 
add the estradiol: 0.1%. After the assay, cell counts were performed. 
The next experiment utilized extracts that were made by the Patchel and Park MQP team. These 
were different types of phytoestrogens with methanol. These included Promensil, Natrol Soy, and Black 
Cohosh. These phytoestrogens were made using an extraction method, which included being ground into 
a fine powder, added to methanol and refluxed using a water jacketed reflux condenser. Each 
phytoestrogen was filtered using 0.45 micron Whatmann syringe filter and the filtered and unfiltered 
extracts were added to the cells. The phytoestrogens were added at a 1% concentration (V/V) and 
methanol was used as a control. After the assay, pictures were taken of the cells and cell counts were 
performed. 
The final experimental condition for MCF7 cells was testing the different fractions that were collected 
from HPLC. The different fractions collected were the finger print region and peak from Promensil. 
Methanol was run through the HPLC and was collected at the same time points to be used as a control. 
These fractions were lyophilized overnight in 50 mL conical tubes to concentrate them and then were 
brought back up in 10 µL of methanol. The 10 µL were added to the cells so that they were at 1% of the 
total volume. After the assay, pictures were taken of the cells and cell counts were performed. 
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Bradford Assay 
Cells were removed from the plates by trypsinization and pelleted by centrifugation. The cell 
pellets were resuspended in 50ul of PBS. Total cell protein was determined using the Bradford protein 
assay.  
Western blotting and Immunodetection 
 
Pelleted cells were resuspended,  lysed, subjected to gel electrophoresis under denaturing conditions and 
transferred to PVDF membranes using a semi-dry transfer apparatus (Current Protocols in Molecular 
Biology (John Wiley & Sons, 2012).  Immunodetection was carried out using monoclonal antibodies to 
PCNA and caspase-3.  Briefly, following transfer, membranes were blocked using 5% non-fat dry milk 
and then incubated overnight with the primary antibody.  After washing with TBS (Tris buffered saline: 
10mM Tris, ph7.4, 150 mM NaCl)) and 1% Tween-20, alkaline phosphatase secondary antibody was 
added.  Following incubation and subsequent washing, detection was accomplished using NBT/BCIP.  
Results 
Phytoestrogens Background 
The three phytoestrogen used were Promensil, Black Cohosh, and Natrol Soy.  The 
phytoestrogens, originally in pill form, were extracted and brought into to solution in 100% methanol.  
The extracts were produced using a reflux condenser (Patchel and Park, 2011).  The phytoestrogens were 
still in a crude form so each was filtered using 0.45 micron Whatmann syringes.  Both the filtered and 
unfiltered versions were used for testing on the cells.  
Estrogen Sensitivity 
Estrogen sensitivity was tested to confirm the model system and to make sure that the estrogen 
concentration that was being used as a positive control is effective. The effect of estrogen on the MCF7 
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and T47D cell lines was tested as per the methods.  Figure 4 below shows the cell counts and protein data 
that were performed to measure estrogen sensitivity. The measurement is a percent of the ethanol control, 
since the estrogen was brought into solution using ethanol. Statistical analysis was not conducted due to 
small sample size; data are presented as a percent of control. The cells proliferated with a concentration of 
10
-9
 estradiol in ethanol. Each bar represents an average of three trials.  
 
Figure 4: Estrogen response of MCF7 Cells: This graph shows the cell counts that were performed to measure estrogen 
sensitivity. The measurement is a percent of the ethanol control. The cells proliferated with a concentration of 10-9 estradiol in 
ethanol. Each bar represents an average of three trials.  
 
For the T47D cells the estrogen sensitivity was tested in a similar manner.  The T47D cells, 
however, were also assayed for protein content and subjected to immunodetection for caspase-3 and 
PCNA.  This data is found in figure 5. 
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Figure 5: Estrogen sensitivity of T47D cells: Tests were run at an estrogen concentration of 10-9M.  PCNA and caspase analysis 
was performed using ImageJ software on the gel pictures.  
 
Effect of Phytoestrogens 
In the MCF7 breast cancer cell line there have been previous studies that suggest phytoestrogens 
play an anti-proliferative role in cell growth. In a previous MQP, specific phytoestrogens were shown to 
have anti-proliferative characteristics. These phytoestrogens include Promensil, Natrol Soy, and Black 
Cohosh.  
MCF7 and T47D Cell Proliferation Assay with Whole Extracts 
The MCF7 cell proliferation assay tested the difference in effects of filtered and unfiltered 
phytoestrogens. This was done because the phytoestrogen extracts were filtered before being run through 
the HPLC. This assay was done to test if filtering affected the phytoestrogens’ anti-proliferative effect. 
This assay tested the effect of Promensil, Natrol Soy, and Black Cohosh at a concentration of 2% in 
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phenol red free DMEM with 10% charcoal stripped fetal bovine serum for the MCF7 cells.   The 
phytoestrogen response of T47D cells was done with the filtered extracts only.  These assays were done 
with a concentration of 1% phytoestrogen extract. Total protein as well as cell counts for T47D cells, are 
also graphically displayed for each of the three phytoestrogens.  This data is shown in figures 7, 8 and 9.  
The effects were measured after 72 hours in the presence of the extract. Methanol was used as a control.  
 
Figure 6: Phytoestrogen response of MCF7 cells: Two samples, one filtered and one unfiltered, for each of the phytoestrogens, 
Promensil, Soy, and Black Cohosh were used to examine the effect on the MCF7 cell line. The data is shown above as a percent 
of the methanol control. Each phytoestrogen showed a greater effect when it was not filtered. 
Figure 6 shows the results of the MCF7 Proliferation assay as measured by cell counts from the 
wells containing the phytoestrogen extract as a percent of the methanol control. These cell counts were all 
performed in triplicate. After 72 hours cell counts of the MCF7 cells demonstrated an anti-proliferative 
effect of the unfiltered phytoestrogens by more than 10% of the ethanol control. Promensil and Black 
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Cohosh showed greater effects than Natrol Soy, which actually showed a proliferative effect when it was 
filtered before applying it to the cells.  
 
Figure 7: Black Cohosh response of T47D cells: Tests were run at a Black Cohosh concentration of 1% (V/V). PCNA and 
caspase analysis was performed using ImageJ software on the gel pictures. 
 
Figure 7 shows the effect of Black Cohosh on the T47D cells.  As the amount of time with extract added 
increased, the cell counts, protein totals, and PCNA levels decreased.  The opposite was true for the 
caspase levels, which increased over time.  The decreasing PCNA levels indicate less cell proliferation 
and the increasing caspase levels indicate a higher amount of cell death.    
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Figure 8: Promensil response of T47D cells: Tests were run at a Promensil concentration of 1% (V/V).  PCNA and caspase 
analysis was performed using ImageJ software on the gel pictures. 
 
Figure 8 shows the effect of Promensil on the T47D cell line.  While the cell counts remained mostly 
stable, there is some indication of decreasing PCNA levels and increasing caspase levels which may 
indicate an anti-proliferative effect.   
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Figure 9: Natrol Soy response of T47D cells: Tests were run at a Natrol Soy concentration of 1% (V/V).  PCNA and caspase 
analysis was performed using ImageJ software. 
 
Figure 9 shows the effect of Natrol Soy on T47D cells.  The day two data showing a decrease in cell 
counts and PCNA levels as well as an increase in caspase likely warrants further investigation.  At other 
time points, Natrol Soy appears to have little to no anti-proliferative effect.  
HPLC 
The filtered extracts of the phytoestrogens were subjected to HPLC using a C18 silica column.  
The HPLC was used to separate the components of the samples were separated using reverse phase 
chromatography to try to isolate the active fraction of the overall phytoestrogen.  The samples were run 
through a C18 column with the solvents used were 10mM ammonium acetate, 0.1% (V/V) triflouroacetic 
acid in a gradient fashion as detailed in Methods.  All three of the filtered versions of the phytoestrogens 
were run through the HPLC machine and the chromatograms were reviewed.  After the filtered Promensil 
was run through the HPLC there was a peak that was observed at 23 minutes.  The observed peak was 
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collected at the time point 21.5-25 minutes to ensure that the peak was collected.  As a control 100% 
methanol was run through the HPLC under the same conditions and collected at the same time point.  
These chromatograms in Figure 5 show the HPLC tracings for methanol at the top and Promensil at the 
bottom. The peak at 23 minutes was collected to be added to MCF7 cells. This was selected because it 
was the largest peak that was not in the fingerprint region. On the Promensil chromatogram, Figure 10, a 
fingerprint region was also observed 1.5-7 minutes and collected to test the effect on the cells as well.  
Methanol was collected at the same time point to be used as a control.  
 
 
Figure 10: Promensil vs. Methanol HPLC: These chromatograms show the HPLC spectrophotometer reading of Promensil (A) 
and methanol (B). The peak at 23 minutes was collected to be added to MCF7 cells. This data can be seen in figure 11. 
 
These fractions, one from Promensil and one from methanol were collected to isolate the peak of 
the chromatogram. Both samples were lyophilized and aplied to MCF7 cells in culture as detailed in the 
methods.  The cells were in a 24 well plate initiallycontaining 75,000 cells per well calculated through 
cell counts.  Figure 11 shows the cell count as a percent of control, methanol, after three days. 
 
A B 
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Figure 11: MCF7 response to HPLC fraction: HPLC was used to isolate a peak from Promensil in a methanol solution.  The 
same time frame was collected from a sample of methanol as a control. These peaks were concentrated and added to the MCF7 
cells.  
 
When compared to the methanol control, the peak fraction from the Promensil extract reduced the 
cell counts by  about 25%.. This experiment was done one time with triplicate wells. 
Modified T47D-KBluc 
 Along with the MCF7 and T47D cell lines, a modified T47D cell line was used.  The T47D-
KBluc is a cell line that has been transfected with estrogen responsive (ERE) luciferase.  (Pianjing , 
Thiantanawat, Rangkadilok, Watcharasit, Mahidol, & Satayavivad, 2011) 
These cells were used in a single experiment under the same conditions as the MCF7 and T47D cell lines.  
They were plated on a 96 well plate and phytoestrogens were applied, along with estrogen as a positive 
control, ethanol as a negative control for the estrogen and methanol as a negative control for the 
phytoestrogens.  After incubation, a luminescent cells assay was completed to determine if the 
phytoestrogen were acting through the estrogen receptor of the cells.  The luminescent cell assay reads 
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and collects the amount of light emitted from each of the wells.  This assay was only run once.  The data 
collected, shown below in figure 12, was inconclusive due to the high intensity of the signal in the 
negative control samples, ethanol and methanol.   
 
Figure 12: Luminescent Cell Assay: A fluorescent plate reader was used to collect the amount of luminescent light emitted 
from the cells. 
 
This assay should be completed multiple times to create more reliable data and for conclusions to be 
created about whether or not the phytoestrogens are acting through the estrogen receptor.     
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Conclusions 
The purpose of this MQP was to validate the claim that phytoestrogens have an anti-proliferative 
effect on estrogen sensitive cells and to further study which specific compounds might be responsible for 
this effect through fractionation studies.  Another objective was to determine whether or not the effects 
were being mediated through the estrogen receptor using the T47D KBluc cells with the ERE-luciferase 
reporter construct. .  The anti-proliferative effects of Black Cohosh were validated on both MCF7 and 
T47D cell lines, as shown in figures 6 and 7. This is supported by the previous research performed with 
MCF7 cells (Park and Patchel, 2011).   The T47D cell line showed similar results, which confirms that 
Black Cohosh has an anti-proliferative effect on multiple breast cancer cells lines.  While there are 
indications that Promensil may have similar effects to Black Cohosh, the T47D data did not show enough 
of an effect to validate the effects of Promensil.    Natrol Soy showed little to no anti-proliferative effect 
on either cell line and likely does not warrant any further investigation.  The HPLC separation identified 
one major peak that appears to have an anti-proliferative effect and certainly deserves further study.  
Recommendations 
 
There should be further experiments done to further explore the mechanism of action of 
phytoestrogens in reducing breast cancer cell growth. The luminescent cell assay, with T47D-
KBluc cells, should be optimized so that the controls are effective. This will then show whether 
the phytoestrogens are acting through the estrogen receptor.  If another cell line that is not 
estrogen sensitive is tested, then this will show whether the phytoestrogens are toxic or just 
having an effect on breast cancer cells. The HPLC fraction should be tested on T47D cells to 
further show that there is an anti-proliferative effect. Western blots should also be performed on 
both cell lines with the fractions added to them to measure PCNA and caspase levels. Different 
batches of phytoestrogen pills from the same companies should be used for HPLC in addition to 
20 
 
being tested on the cell lines, because different batches can have different components in them.  
This will be useful to compare to the HPLC runs that have already been done.  Identification of 
additional components in the extracts and determination of their effects on cell growth may 
reveal specific phytoestrogens that have specific anti-proliferative effects.  This may be an 
important way to allow women to relieve the symptoms of menopause without increasing their 
risk of breast cancer.   
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